Community-reported insights only, not medical advice. Data recency varies by source; check timestamps and confidence before making treatment decisions.

← Back to Brands

Papers

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
42
Portfolio
3 Strains
Mentions (90d)
26
Brand Score (90d)
62
vs Market Avg: 63 vs All Time: 64
Below Average

Rating lower than the 90d community baseline.

Medication Portfolio (3)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
17
Yoda Cap
29.0%
0
-
65
142
28.0%
23
61
61
432
Gushface
28.0%
3
73
73